DD137670A5 - Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung - Google Patents

Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung

Info

Publication number
DD137670A5
DD137670A5 DD77207969A DD20796977A DD137670A5 DD 137670 A5 DD137670 A5 DD 137670A5 DD 77207969 A DD77207969 A DD 77207969A DD 20796977 A DD20796977 A DD 20796977A DD 137670 A5 DD137670 A5 DD 137670A5
Authority
DD
German Democratic Republic
Prior art keywords
producing
pharmaceutical composition
new pharmaceutical
new
composition
Prior art date
Application number
DD77207969A
Other languages
German (de)
English (en)
Inventor
Michel L Thominet
Jacques Perrot
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of DD137670A5 publication Critical patent/DD137670A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
DD77207969A 1976-07-19 1977-07-15 Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung DD137670A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7622180A FR2358892A1 (fr) 1976-07-19 1976-07-19 N(1'-allyl 2'-pyrrolidylmethyl)2,3-dimethoxy 5-sulfamoyl benzamide, ses derives

Publications (1)

Publication Number Publication Date
DD137670A5 true DD137670A5 (de) 1979-09-19

Family

ID=9175947

Family Applications (2)

Application Number Title Priority Date Filing Date
DD7700200091A DD132492A5 (de) 1976-07-19 1977-07-15 Verfahren zur herstellung von n-(1-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid und seinen derivaten
DD77207969A DD137670A5 (de) 1976-07-19 1977-07-15 Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD7700200091A DD132492A5 (de) 1976-07-19 1977-07-15 Verfahren zur herstellung von n-(1-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid und seinen derivaten

Country Status (38)

Country Link
US (1) US4499019A (xx)
JP (1) JPS5338631A (xx)
AR (1) AR214330A1 (xx)
AT (1) AT365570B (xx)
AU (1) AU509291B2 (xx)
BE (1) BE856289A (xx)
CH (1) CH627162A5 (xx)
CS (1) CS219885B2 (xx)
CY (1) CY1036A (xx)
DD (2) DD132492A5 (xx)
DK (1) DK156646C (xx)
EG (1) EG12911A (xx)
ES (1) ES460621A1 (xx)
FI (1) FI67213C (xx)
FR (1) FR2358892A1 (xx)
GB (1) GB1539319A (xx)
GR (1) GR60836B (xx)
HK (1) HK17880A (xx)
HU (1) HU174981B (xx)
IE (1) IE46171B1 (xx)
IL (1) IL52547A (xx)
IN (1) IN146993B (xx)
LU (1) LU77782A1 (xx)
MC (1) MC1153A1 (xx)
MX (1) MX4711E (xx)
NL (1) NL174347C (xx)
NO (1) NO146598C (xx)
NZ (1) NZ184634A (xx)
OA (1) OA05704A (xx)
PH (1) PH12838A (xx)
PL (1) PL104244B1 (xx)
PT (1) PT66819B (xx)
RO (1) RO71691A (xx)
SE (1) SE425243B (xx)
SU (1) SU695556A3 (xx)
YU (1) YU40677B (xx)
ZA (1) ZA774256B (xx)
ZM (1) ZM5477A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
JPS5639431A (en) * 1979-09-06 1981-04-15 Susumu Yagyu Colorimeter having two-light pass length and two-wave length
FR2478093A1 (fr) * 1980-03-12 1981-09-18 Ile De France Nouveau procede de preparation de n-(1-alkyl (ou allyl) 2-pyrrolidinyl-methyl)2-methoxy (ou 2,3-dimethoxy) 5-sulfamoyl (ou sulfamoyl substitue)
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
US8420624B2 (en) * 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
CN105481733A (zh) * 2015-12-30 2016-04-13 苏州诚和医药化学有限公司 一种一步法合成2-甲氧基-5-氨磺酰基苯甲酸甲酯的方法

Also Published As

Publication number Publication date
FR2358892A1 (fr) 1978-02-17
NO772530L (no) 1978-01-20
ATA511677A (de) 1981-06-15
IN146993B (xx) 1979-10-20
NL174347B (nl) 1984-01-02
MC1153A1 (fr) 1978-04-17
PL199723A1 (pl) 1978-04-24
AT365570B (de) 1982-01-25
PT66819A (fr) 1977-08-01
FI67213B (fi) 1984-10-31
YU40677B (en) 1986-04-30
IE46171L (en) 1978-01-19
SE425243B (sv) 1982-09-13
YU173977A (en) 1983-01-21
GR60836B (en) 1978-08-31
SE7708176L (sv) 1978-01-20
PH12838A (en) 1979-09-05
HK17880A (en) 1980-04-11
NL7707982A (nl) 1978-01-23
FI67213C (fi) 1985-02-11
FI772214A (xx) 1978-01-20
MX4711E (es) 1982-08-11
BE856289A (fr) 1977-12-30
GB1539319A (en) 1979-01-31
ZM5477A1 (en) 1978-05-22
AU2702677A (en) 1979-01-18
LU77782A1 (xx) 1977-10-17
RO71691A (ro) 1982-09-09
IE46171B1 (en) 1983-03-23
NO146598C (no) 1982-11-03
NO146598B (no) 1982-07-26
AU509291B2 (en) 1980-05-01
CH627162A5 (xx) 1981-12-31
OA05704A (fr) 1981-05-31
US4499019A (en) 1985-02-12
PL104244B1 (pl) 1979-08-31
NL174347C (nl) 1984-06-01
SU695556A3 (ru) 1979-10-30
EG12911A (en) 1980-12-31
CS219885B2 (en) 1983-03-25
AR214330A1 (es) 1979-05-31
DK326377A (da) 1978-01-20
IL52547A (en) 1980-01-31
NZ184634A (en) 1978-11-13
ZA774256B (en) 1978-06-28
ES460621A1 (es) 1978-05-01
FR2358892B1 (xx) 1978-12-15
JPS554724B2 (xx) 1980-01-31
PT66819B (fr) 1978-12-22
IL52547A0 (en) 1977-10-31
HU174981B (hu) 1980-04-28
DK156646C (da) 1990-02-05
JPS5338631A (en) 1978-04-08
DK156646B (da) 1989-09-18
CY1036A (en) 1980-08-01
DD132492A5 (de) 1978-10-04

Similar Documents

Publication Publication Date Title
AT355238B (de) Verfahren zur herstellung eines neuen hentriakontapeptids
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
DD132786A5 (de) Verfahren zur herstellung eines neuen oximaethers
AT356637B (de) Verfahren zur herstellung von neuen n-acyl- taurinsalzen
ATA495577A (de) Verfahren zur herstellung von neuen 7-beta(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT359643B (de) Verfahren zur herstellung von neuen 4"-ery- thromycin-a-derivaten
AT369987B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
DD137670A5 (de) Verfahren zur herstellung einer neuen pharmazeutischen zusammensetzung
AT374682B (de) Verfahren zur herstellung einer pharmazeutischen zusammensetzung
AT358006B (de) Verfahren zur herstellung der neuen 4-iso- hexyl-1-methylcyclohexancarbonsaeure
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
ATA219179A (de) Verfahren zur herstellung von neuen demethyl- maytansinoiden
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT363593B (de) Verfahren zur herstellung eines neuen peptolidgemisches
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT357669B (de) Verfahren zur herstellung einer neuen anti- biotischen substanz
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT357670B (de) Verfahren zur herstellung eines neuen anti- biotikums
AT352271B (de) Verfahren zur herstellung einer neuen antibiotischen substanz
AT352103B (de) Verfahren zur herstellung eines neuen dicyanovinylhydrazonomalonitrils
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
AT371711B (de) Verfahren zur herstellung einer pharmazeutischen zubereitung
ATA472979A (de) Verfahren zur herstellung eines neuen praevitamins
ATA93882A (de) Verfahren zur herstellung eines neuen 3-vinyl -cephalosporins
ATA770879A (de) Verfahren zur herstellung von neuen 4''- -erythromycin-a-derivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee